The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

Published Date: 22 Sep 2023

The US Food and Drug Administration (FDA) has approved JAK inhibitor momelotinib (Ojjaara) as the initial treatment specifically for.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds common genetic target may halt breast cancer cell growth

2.

Decoding calcifications in breast cancer: Towards personalized medicine

3.

Prostate cancer Q&A: Improving detection and reducing overtreatment

4.

Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.

5.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot